Outlook Therapeutics, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Outlook Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Outlook Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 147 %.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2023 was -3.74K %, a 1509% decline from 2022.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2022 was -233 %, a 69.9% increase from 2021.
  • Outlook Therapeutics, Inc. annual Return On Equity for 2021 was -772 %, a 306% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -3.74K -3.51K -1509% Oct 1, 2022 Sep 30, 2023
2022 -233 +540 +69.9% Oct 1, 2021 Sep 30, 2022
2021 -772 -1.15K -306% Oct 1, 2020 Sep 30, 2021
2020 374 +195 +109% Oct 1, 2019 Sep 30, 2020
2019 179 +55.5 +44.9% Oct 1, 2018 Sep 30, 2019
2018 124 -16.1 -11.5% Oct 1, 2017 Sep 30, 2018
2017 140 Oct 1, 2016 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.